1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Who's interviewing

Discussion in 'Zogenix' started by Anonymous, Mar 22, 2015 at 10:45 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Well Im happy to still have a job with Pernix while I look for the next opportunity. What are everyones thoughts? Are you interviewing? Planning on making a go of it with Pernix? What?
     

  2. Anonymous

    Anonymous Guest

    Who isn't interviewing? Are you really that dumb?
     
  3. Anonymous

    Anonymous Guest

    well I wish I could say that I had some hope but I dont think Pernix is any more capable of making Zohydro successful than Zogenix was. Im not convinced that they can do much about the MC situation despite their beleif that they can. I dont want to look for a job again as I have only been here a little over a year and dont want to appear to be job hopping but I dont feel like I have much choice.
     
  4. Anonymous

    Anonymous Guest

    that hope isn't worth a caffe latte at Starbucks. Listen and listen closely dumbass. Start interviewing.
     
  5. Anonymous

    Anonymous Guest

    yeah listen closely dumbass hes smart and knows everything. What is ya, ignant?
     
  6. Anonymous

    Anonymous Guest

    How many SAM's are left after all of the "non- viable" territory BS layoffs?
     
  7. Anonymous

    Anonymous Guest

    2